candesartan has been researched along with Cerebral Cryptococcosis in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of the study was to investigate the efficacy of acetazolamide (AZA), candesartan (CAN), and triciribine (TCBN), in combination with the antifungal fluconazole, on C." | 1.91 | A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis. ( Alanazi, AH; Chastain, DB; Franco-Paredes, C; Henao-MartÃnez, AF; Lin, X; Narayanan, SP; Parvathagiri, V; Rudraraju, M; Shan, S; Somanath, PR, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alanazi, AH | 1 |
| Chastain, DB | 1 |
| Rudraraju, M | 1 |
| Parvathagiri, V | 1 |
| Shan, S | 1 |
| Lin, X | 1 |
| Henao-MartÃnez, AF | 1 |
| Franco-Paredes, C | 1 |
| Narayanan, SP | 1 |
| Somanath, PR | 1 |
1 other study available for candesartan and Cerebral Cryptococcosis
| Article | Year |
|---|---|
A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis.
Topics: Acetazolamide; Animals; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Meningitis, | 2023 |